Adagrasib
http://dbpedia.org/resource/Adagrasib an entity of type: Thing
Adagrasib (INN, codenamed MRTX-849), is an experimental cancer drug being developed by Mirati Therapeutics. It acts as a covalently binding inhibitor for a mutant form of the protein KRAS called G12C, which is commonly present in various forms of cancer and acts as a growth factor. It has shown promising results in pre-clinical testing and is currently in clinical trials.
rdf:langString
rdf:langString
Adagrasib
xsd:integer
67027951
xsd:integer
1116636629
rdf:langString
None
xsd:integer
32
xsd:integer
2326521
xsd:integer
1
rdf:langString
DB15568
xsd:integer
1
xsd:integer
35
rdf:langString
{-4-[7--2-{[-1methylpyrrolidin-2-yl]methoxy}-5,6,7,8tetrahydropyrido[3,4-d]pyrimidin-4-yl]-1-piperazin-2-yl}acetonitrile
rdf:langString
D12301
xsd:integer
7
xsd:integer
2
xsd:integer
138611145
rdf:langString
CN1CCC[C@H]1COC2=NC3=CCN6CCNCCF
xsd:integer
1
rdf:langString
PEMUGDMSUDYLHU-ZEQRLZLVSA-N
xsd:integer
8
rdf:langString
Adagrasib (INN, codenamed MRTX-849), is an experimental cancer drug being developed by Mirati Therapeutics. It acts as a covalently binding inhibitor for a mutant form of the protein KRAS called G12C, which is commonly present in various forms of cancer and acts as a growth factor. It has shown promising results in pre-clinical testing and is currently in clinical trials.
xsd:nonNegativeInteger
5376
xsd:string
2326521-71-3
xsd:string
DB15568
xsd:string
8EOO6HQF8Y
xsd:string
D12301
xsd:string
138611145